financetom
Business
financetom
/
Business
/
Mphasis Q2 net up 9.4% to Rs 299 cr
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Mphasis Q2 net up 9.4% to Rs 299 cr
Oct 23, 2020 1:09 AM

IT firm Mphasis on Thursday reported a 9.4 percent increase in consolidated net profit to Rs 299.2 crore for the September 2020 quarter. The company’s net profit stood at Rs 273.3 crore in the year-ago period, it said in a regulatory filing. Revenue from operations grew 12.8 percent to Rs 2,435.4 crore in the reported quarter from Rs 2,158.1 crore in the year-ago period.

The company said it has registered USD 360 million worth of total contract value (TCV) wins in direct international business, of which 73 percent was in new-generation services. Direct revenue grew 9.7 percent quarter-on-quarter and 25.2 percent year-on-year on a reported basis. In constant currency terms, revenue grew 10.9 percent q-o-q and 18.4 percent y-o-y.

Mphasis’ earnings per share (EPS) grew 9.3 percent y-o-y to Rs 16.04. ”We are pleased with achieving the highest-ever TCV wins for the quarter, as the nature of deals is transformation lead; requiring multiple capabilities and competencies to come together.

”The investments we made in our tribes and squads model are driving growth and differentiation,” Mphasis Chief Executive Officer and Executive Director Nitin Rakesh said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
MIRA Pharmaceuticals'  Marijuana Analog Mira-55 Shows Potent Pain Relief In Preclinical Study, Stock Jumps 50% After Hours
MIRA Pharmaceuticals' Marijuana Analog Mira-55 Shows Potent Pain Relief In Preclinical Study, Stock Jumps 50% After Hours
Jul 2, 2025
MIRA Pharmaceuticals, Inc. ( MIRA ) shares soared to $1.87, an approximate 50.8% jump, during after-hours trading on Wednesday. What Happened: After the announcement of Mira-55, a synthetic analog of marijuana, providing pain relief comparable to morphine, the stock value of MIRA Pharmaceutical exploded, signaling an aggressive investor buying. Mira-55, engineered to selectively activate CB2 receptors, displayed minimal activity at...
France's Maurel et Prom raises stake in Colombia's Sinu-9 gas field
France's Maurel et Prom raises stake in Colombia's Sinu-9 gas field
Jul 2, 2025
July 3 (Reuters) - French oil and gas company Maurel et Prom has agreed to raise its ownership stake in Colombia's Sinu-9 gas field by another 21% for nearly $79 million, it said on Thursday, as it continues to expand its position in the country. The acquisition of additional working interest in the gas block from minority partners brings Maurel...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
As trade war truce with China holds, US lifts curbs for chip design software and ethane
As trade war truce with China holds, US lifts curbs for chip design software and ethane
Jul 2, 2025
* Synopsys ( SNPS ), Cadence and Siemens restoring access for Chinese customers * Ethane producers also informed that curbs lifted * US had escalated countermeasures after Beijing curbed exports of rare earths (Recasts and writes through) By Karen Freifeld and Surbhi Misra NEW YORK, July 2 (Reuters) - The United States has lifted restrictions on exports to China for...
Copyright 2023-2026 - www.financetom.com All Rights Reserved